/
LLC Innovative Medicine University Clinic
| GEL thousands | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| P&L Items | |||||||
| Revenue | Register | Register | Register | Register | 5,325 | Register | Register |
| Adj. Operating Profit¹ | Register | Register | Register | Register | 654 | Register | Register |
| Adj. EBITDA¹ | Register | Register | Register | Register | 2,472 | Register | Register |
| Net Income | Register | Register | Register | Register | 1,302 | Register | Register |
| Margins & Profitability Ratios (%) | |||||||
| Adj. Operating Profit Margin¹ | Register | Register | Register | Register | 12.3% | Register | Register |
| Adj. EBITDA Margin¹ | Register | Register | Register | Register | 46.4% | Register | Register |
| Net Income Margin | Register | Register | Register | Register | 24.5% | Register | Register |
| Balance Sheet Items & Leverage | |||||||
| Total Assets | Register | Register | Register | Register | 23,087 | Register | Register |
| Total Debt² | Register | Register | Register | Register | 8,522 | Register | Register |
| Total Debt² / Adj. EBITDA¹ | Register | Register | Register | Register | 3.45x | Register | Register |
| Total Equity | Register | Register | Register | Register | 13,976 | Register | Register |
| ROAE | Register | Register | Register | Register | 9.8% | Register | Register |
¹ Adj. Operating Profit has been adjusted to exclude non-recurring and one-time items. Adj. EBITDA is calculated by adding back D&A expenses to the adjusted operating profit.
² Total debt includes lease liabilities, where applicable.